Design of Transurethral Bulking Agent Injection Versus Single-Incision Sling Trial
Results from the BASIS study will provide level 1 evidence on the comparative-effectiveness of 2 minimally invasive office-based treatments. Important safety data and 3-year outcomes will help clinicians and patients make informed decisions about primary SUI procedure options.
Authors
- Charles R. Rardin
- H. Harvie
- Emily S. Lukacz (ORCID: https://orcid.org/0000-0002-2189-8927)
- M. Florian-Rodriguez
- Shawn A. Menefee (ORCID: https://orcid.org/0000-0002-8103-7803)
- Benjamin Carper (ORCID: https://orcid.org/0000-0001-5882-2232)
- D. Mazloomdoost
- Kimberly McMillian
- Alison C. Weidner
- Sara Collins
- Brenton Alexander
- for the NICHD Pelvic Floor Disorders Network
Institutions
- National Institutes of Health (US)
- American Institute of Biological Sciences (US)
- Kaiser Permanente (US)
- RTI International (US)
- Brown University (US)
- University of California San Diego (US)
- University of Chicago (US)
- Duke Medical Center (US)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (US)
- Therapeutic Guidelines (AU)
- University of Pennsylvania (US)
- The University of Texas Southwestern Medical Center (US)
Publication Details
- Journal
- Urogynecology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1097/spv.0000000000001702
- Primary Topic
- Pelvic floor disorders treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00